CSL CEO on Financial Results, Business Outlook

Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook. CSL reported a 3.4 percent increase in first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)

Canadian Auto Parts Maker Under Threat by Trump
47:57 - As President Donald Trump pushes to renegotiate NAFTA with Canada and Mexico, a Canadian auto-parts maker is beginning to feel the squeeze. Linamar has 24,500 workers spread around 12 countries. Bloomberg's Gerrit de Vynck talks to the CEO about the challenges ahead. (Source: Bloomberg)
  • Does a U.S. Border Adjustment Tax Have Enough Support?
  • How Will Trump Tax Reform Be Paid For?
  • The Red-State Weatherwoman on a Climate Change Mission